A. I. Green

962 total citations
9 papers, 718 citations indexed

About

A. I. Green is a scholar working on Psychiatry and Mental health, Clinical Psychology and Epidemiology. According to data from OpenAlex, A. I. Green has authored 9 papers receiving a total of 718 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Psychiatry and Mental health, 3 papers in Clinical Psychology and 3 papers in Epidemiology. Recurrent topics in A. I. Green's work include Schizophrenia research and treatment (8 papers), Electroconvulsive Therapy Studies (3 papers) and Substance Abuse Treatment and Outcomes (3 papers). A. I. Green is often cited by papers focused on Schizophrenia research and treatment (8 papers), Electroconvulsive Therapy Studies (3 papers) and Substance Abuse Treatment and Outcomes (3 papers). A. I. Green collaborates with scholars based in United States and Canada. A. I. Green's co-authors include Gregory J. McHugo, Robert E. Drake, Haiyi Xie, Ileana Berman, Demetra M. Pappas, Mary F. Brunette, Ming T. Tsuang, Larry J. Seidman, Stephen V. Faraone and Hongsheng Xie and has published in prestigious journals such as American Journal of Psychiatry, Schizophrenia Bulletin and Schizophrenia Research.

In The Last Decade

A. I. Green

8 papers receiving 679 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
A. I. Green United States	8	580	152	132	131	114	9	718
Mark McGee United States	6	476 0.8×	147 1.0×	128 1.0×	111 0.8×	71 0.6×	7	691
Ruth Ohlsen United Kingdom	14	439 0.8×	98 0.6×	60 0.5×	97 0.7×	177 1.6×	38	708
M. Gutiérrez Spain	15	455 0.8×	133 0.9×	63 0.5×	82 0.6×	60 0.5×	31	599
Stanley Mutsatsa United Kingdom	9	466 0.8×	143 0.9×	41 0.3×	142 1.1×	128 1.1×	16	581
Katherine Tracy United States	15	649 1.1×	286 1.9×	183 1.4×	49 0.4×	62 0.5×	19	1.0k
Franck Baylé France	14	325 0.6×	198 1.3×	65 0.5×	55 0.4×	115 1.0×	28	664
B. Andresen Germany	13	440 0.8×	303 2.0×	179 1.4×	113 0.9×	228 2.0×	20	873
Stephen M. Erhart United States	8	802 1.4×	232 1.5×	79 0.6×	191 1.5×	172 1.5×	8	1.0k
Joanne McCormack United States	11	413 0.7×	123 0.8×	62 0.5×	73 0.6×	215 1.9×	13	696
Evelyn Howanitz United States	8	465 0.8×	90 0.6×	97 0.7×	148 1.1×	168 1.5×	12	612

Countries citing papers authored by A. I. Green

Since Specialization

Citations

This map shows the geographic impact of A. I. Green's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by A. I. Green with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites A. I. Green more than expected).

Fields of papers citing papers by A. I. Green

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by A. I. Green. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by A. I. Green. The network helps show where A. I. Green may publish in the future.

Co-authorship network of co-authors of A. I. Green

This figure shows the co-authorship network connecting the top 25 collaborators of A. I. Green. A scholar is included among the top collaborators of A. I. Green based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with A. I. Green. A. I. Green is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

9 of 9 papers shown

Lieberman, Jeffrey A., G.D. Tollefson, A. I. Green, et al.. (2009). Comparative efficacy and safety of atypical and conventional antipsychotic drugs in first-episode psychosis: A randomized, double-blind trial of olanzapine versus haloperidol (American Journal of Psychiatry (2003) 160, (1396-1404)). American Journal of Psychiatry. 166(8). 12 indexed citations

McHugo, Gregory J., et al.. (2005). Enhancing Validity in Co-occurring Disorders Treatment Research. Schizophrenia Bulletin. 32(4). 655–665. 31 indexed citations

Brunette, Mary F., Robert E. Drake, Hongsheng Xie, Gregory J. McHugo, & A. I. Green. (2005). Clozapine Use and Relapses of Substance Use Disorder Among Patients With Co-occurring Schizophrenia and Substance Use Disorders. Schizophrenia Bulletin. 32(4). 637–643. 90 indexed citations

Alphs, Larry, Ravi Anand, Herbert Y. Meltzer, et al.. (2004). The International Suicide Prevention Trial (InterSePT): Rationale and Design of a Trial Comparing the Relative Ability of Clozapine and Olanzapine To Reduce Suicidal Behavior in Schizophrenia and Schizoaffective Patients. Schizophrenia Bulletin. 30(3). 577–586. 30 indexed citations

Faraone, Stephen V., A. I. Green, Larry J. Seidman, & Ming T. Tsuang. (2001). "Schizotaxia": Clinical Implications and New Directions for Research. Schizophrenia Bulletin. 27(1). 1–18. 79 indexed citations

Green, A. I., Jayendra K. Patel, Michael Banov, et al.. (2000). Clozapine in the Treatment of Refractory Psychotic Mania. American Journal of Psychiatry. 157(6). 982–986. 89 indexed citations

Drake, Robert E., Haiyi Xie, Gregory J. McHugo, & A. I. Green. (2000). The Effects of Clozapine on Alcohol and Drug Use Disorders Among Patients With Schizophrenia. Schizophrenia Bulletin. 26(2). 441–449. 213 indexed citations

Berman, Ileana, et al.. (1997). Differential relationships between positive and negative symptoms and neuropsychological deficits in schizophrenia. Schizophrenia Research. 25(1). 1–10. 173 indexed citations

Green, A. I., et al.. (1994). Psychosis, Delirium, or Both?. Harvard Review of Psychiatry. 2(1). 34–38. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact